FOLH1 and neoplasm: With 2.2.3, the tumor-to-kidney ratio is 1.76, slightly lower than for 64Cu-DOTHA2-PSMA, and the tumor-to-liver ratio is 92.8, importantly higher than for 64Cu-DOTHA2-PSMA.